{"id":"mepixanox","rwe":[],"tags":[{"label":"mepixanox","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"R07AB09","category":"atc"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"pimexone","offLabel":[],"synonyms":["mepixanox","mepixanthone","pimexone"],"timeline":[],"approvals":[],"brandName":"Pimexone","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"mepixanox","explanation":"Imagine your body's cells have a factory inside them that produces certain chemicals. Pimexone is like a key that blocks the factory's production line, reducing the amount of those chemicals. This helps to treat various conditions by altering the chemical balance in the body.","oneSentence":"Pimexone works by inhibiting a specific enzyme or pathway to produce its therapeutic effect.","technicalDetail":"Pimexone acts as a selective inhibitor of a specific enzyme, thereby modulating the downstream signaling pathways and exerting its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1701","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEPIXANOX","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:34:49.854870","biosimilars":[],"competitors":[{"drugName":"doxapram","drugSlug":"doxapram","fdaApproval":"1965-06-23","genericCount":2,"patentStatus":"Off-patent — generic available","relationship":"same-class"}],"genericName":"mepixanox","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"doxapram","brandName":"doxapram","genericName":"doxapram","approvalYear":"1965","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7419T4YQQW","CHEBI":"CHEBI:135373","INN_ID":"5296","UMLSCUI":"C0071070","ChEMBL_ID":"CHEMBL2104462","KEGG_DRUG":"D07410","DRUGBANK_ID":"DB13579","PUBCHEM_CID":"65687","MESH_SUPPLEMENTAL_RECORD_UI":"C033221"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"pharmacokinetics":{"source":"DrugCentral","bioavailability":"65%"},"publicationCount":1,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"R07AB09","allCodes":["R07AB09"]},"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pimexone, also known as Mepixanox, is a small molecule drug in the mepixanox class. Its original development is attributed to an unknown entity, and it is currently owned by an unspecified company. The target and approved indications for Pimexone are not publicly disclosed. The commercial status of Pimexone is unclear, with no information available on its patent status or generic manufacturers. Key safety considerations for Pimexone are not specified.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}